GB1152607A - Antigenic Compositions - Google Patents

Antigenic Compositions

Info

Publication number
GB1152607A
GB1152607A GB1079167A GB1079167A GB1152607A GB 1152607 A GB1152607 A GB 1152607A GB 1079167 A GB1079167 A GB 1079167A GB 1079167 A GB1079167 A GB 1079167A GB 1152607 A GB1152607 A GB 1152607A
Authority
GB
United Kingdom
Prior art keywords
antigen
march
aqueous phase
water
antigenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1079167A
Inventor
Allan Lawrence
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB1079167A priority Critical patent/GB1152607A/en
Publication of GB1152607A publication Critical patent/GB1152607A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

1,152,607. Vaccines. PFIZER Ltd. 6 March, 1968 [8 March, 1967], No. 10791/67. Heading A5B. Antigenic compositions comprise a (water-inoil)-in-water multiple emulsion with antigenic material in the disperse aqueous phase, at least part of which is adsorbed on a normally solid adjuvant material e.g. aluminium hydroxide or phosphate. The antigen may also be present in the continuous aqueous phase. Examples relate to preparations in which the antigen is Newcastle disease virus and a multiple clostridial vaccine comprising C. welchii types B, C and D, C. tetani, C. septicum C. oedematiens type B and C. chauvoei. Other antigens are mentioned.
GB1079167A 1967-03-08 1967-03-08 Antigenic Compositions Expired GB1152607A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1079167A GB1152607A (en) 1967-03-08 1967-03-08 Antigenic Compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1079167A GB1152607A (en) 1967-03-08 1967-03-08 Antigenic Compositions

Publications (1)

Publication Number Publication Date
GB1152607A true GB1152607A (en) 1969-05-21

Family

ID=9974331

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1079167A Expired GB1152607A (en) 1967-03-08 1967-03-08 Antigenic Compositions

Country Status (1)

Country Link
GB (1) GB1152607A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053584A (en) * 1975-02-12 1977-10-11 Recherche Et Industrie Therapeutiques Pre-farrowing pregnant sow piglet colibacillosis vaccines and process for their administration to pregnant sows before farrowing
US4578270A (en) * 1983-02-22 1986-03-25 Human Oltoanyagtermelo Es Kutato Intezet Process for the preparation of lyophilized, adsorbed polyvalent vaccines
WO2000037045A2 (en) * 1998-12-22 2000-06-29 Maine Biological Laboratories, Inc. Stabilized water-in-oil-in-water antigen delivery system
WO2003039725A1 (en) * 2001-11-09 2003-05-15 Rhodia Chimie Emulsifying compositions comprising mineral nanoparticles with modified surface
WO2003039724A1 (en) * 2001-11-09 2003-05-15 Rhodia Chimie Multiple emulsions comprising particles of nanometric dimensions with modified surface as stabilizing agents
EP1350556A1 (en) * 2002-03-14 2003-10-08 Wacker-Chemie GmbH Multiple emulsions

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053584A (en) * 1975-02-12 1977-10-11 Recherche Et Industrie Therapeutiques Pre-farrowing pregnant sow piglet colibacillosis vaccines and process for their administration to pregnant sows before farrowing
US4578270A (en) * 1983-02-22 1986-03-25 Human Oltoanyagtermelo Es Kutato Intezet Process for the preparation of lyophilized, adsorbed polyvalent vaccines
WO2000037045A2 (en) * 1998-12-22 2000-06-29 Maine Biological Laboratories, Inc. Stabilized water-in-oil-in-water antigen delivery system
WO2000037045A3 (en) * 1998-12-22 2000-10-26 Maine Biolog Lab Inc Stabilized water-in-oil-in-water antigen delivery system
WO2003039725A1 (en) * 2001-11-09 2003-05-15 Rhodia Chimie Emulsifying compositions comprising mineral nanoparticles with modified surface
WO2003039724A1 (en) * 2001-11-09 2003-05-15 Rhodia Chimie Multiple emulsions comprising particles of nanometric dimensions with modified surface as stabilizing agents
FR2832076A1 (en) * 2001-11-09 2003-05-16 Rhodia Chimie Sa EMULSIFIING COMPOSITIONS COMPRISING MODIFIED SURFACE NANOMETRIC MINERAL PARTICLES AND SURFACTANT AGENTS FORMED BY SUCH PARTICLES
FR2832074A1 (en) * 2001-11-09 2003-05-16 Rhodia Chimie Sa MULTIPLE EMULSIONS COMPRISING PARTICLES OF NANOMETRIC DIMENSIONS OF MODIFIED SURFACE AS STABILIZING AGENTS
EP1350556A1 (en) * 2002-03-14 2003-10-08 Wacker-Chemie GmbH Multiple emulsions
US7722891B2 (en) 2002-03-14 2010-05-25 Wacker Chemie Ag Multiple emulsions

Similar Documents

Publication Publication Date Title
GB1183506A (en) New vaccines for combating influenza and the preparation thereof
GB1152607A (en) Antigenic Compositions
GB1292803A (en) Improvements relating to the production of antigens
IT983058B (en) METHOD FOR THE PREPARATION OF VACCINES FOR THE IMMUNIZATION OF CATS AGAINST THE INFECTIOUS LA ENTERITIS VIRUS THE RINOTRACHEITE VIRUS THE PICORNA VIRUS OF FELINI AND CO VACCINES OBTAINED
IE35138B1 (en) Poultry vaccine
GB1486186A (en) Vaccines against feline leukaemia and the group of diseases associated with feline leukaemis/virus infection
GB1256457A (en) Diethylaminoethyldextran (deae-d) as adjuvant for vaccines for active immunisation
IT1043894B (en) DEAD VACCINE AGAINST RINITIS INFECTIVE ATRCFIC PIGS AND PROCEDURE FOR ITS PREPARATION
ES2068215T3 (en) SYNTHETIC VACCINE AGAINST GLOSOPEDIA AND PROCEDURE FOR ITS PREPARATION.
GB1212886A (en) Equine vaccine and vaccination treatment
CA980251A (en) Adjuvants for vaccines and vaccine preparations containing them
GB1083815A (en) Vaccine adjuvants
Morein et al. Vaccination against herpesvirus, fiction or reality
Coggins et al. Serological Comparison with Rabbit Antisera of Hog Cholera Virus and Bovine Virus Diarrhea Virus.
GB1434181A (en) Vaccine for the prevention and treatment of vascular conditions
CA962593A (en) Highly attenuated newcastle disease virus vaccine and production thereof
Flanagan et al. Response to experimental infection with mumps virus in rhesus monkeys
Veiga et al. Cell mediated immune response in human antirabies revaccination
GR33984B (en) METHOD FOR VACCINE PREPARATION.
Philip et al. Secondary, Hypergonadotrophic Amenorrhoea
GB1324619A (en) Combined infectious bronchitis and newcastle disease vaccines
GB1293310A (en) Vaccine
de la Fe Contributions to the immunoprevention knowledge against caprine contagious agalactia in the island of Gran Canaria (Spanish text)
SU548046A1 (en) Diluent of lyophilized vaccine strain of madness virus
MASLOV On the problem of the effectiveness of the inhalation method of vaccination. Part II. The immunological effectiveness of inhalation immunization with killed vaccines during utilization of medium-and fine-dispersion aerosols

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees